C. P. Nogeirie

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Twenty-five patients with non-small cell lung cancer (NSCLC) were treated with high-dose methotrexate with citrovorum factor resuce (HDMTX-CFR), mechlorethamine (HN2) and procarbazine (PCZ). Nineteen patients are evaluable for response. One patient had partial remission which lasted for 11 weeks. Nine patients had stable disease lasting for 6–22 weeks.(More)
  • 1